Home / Drug Classifications and Understanding Types of Drugs / Mescaline’s Effects, Risks, Treatment, and Legal Status in Canada
Written by Marc Bernard, Addiction Case Manager & Referral Specialist— Clinically Reviewed by Susan Chubbs, Certified Drug & Alcohol Treatment Specialist
Professional member affiliations
Mescaline is a naturally occurring psychedelic substance found in several cactus species, most notably the Peyote and San Pedro Cactus. For centuries, these plants have been used in ceremonial and spiritual practices. Today, it is recognized as a powerful hallucinogenic drug that can significantly alter perception, mood, and thinking.
In Canada, mescaline is considered a controlled substance when used outside approved religious or scientific contexts. Understanding the effects, risks, and treatment considerations associated with this drug is important for individuals, families, and healthcare professionals seeking accurate information about psychedelic drug use.
Mescaline is classified as a hallucinogen, a category of drugs that affects sensory perception, emotions, and cognitive function. It may be consumed by eating dried cactus buttons, drinking brewed cactus tea, or taking synthetic preparations.
ITS EFFECTS CAN LAST BETWEEN 8 AND 12 HOURS, DEPENDINGON:
the amount used,
the individual’s tolerance,
the body chemistry,
the environment.
Some individuals experience primarily visual and sensory distortions, while others experience intense emotional or psychological changes.
Although it is sometimes described as producing spiritual or introspective experiences, reactions can vary significantly from person to person.
Mescaline primarily interacts with serotonin receptors in the brain, similar to other psychedelic substances such as LSD and Psilocybin. These interactions disrupt normal brain communication pathways.
IT CAN ALTER:
Changes in how a person sees or hears things. Experiencing sights or sounds that are distorted, intensified, or not actually present.
This can include seeing people, or objects, or hearing voices, music, or noises that do not exist.
A disturbance in the brain’s perception of time.
It affects how the speed, duration, or order of events are experienced, often along with altered awareness of one’s surroundings or sense of self
An increased responsiveness to emotions, where feelings may be experienced more deeply or intensely than usual.
A person may become more affected by thoughts, memories, music, interactions, or surroundings, leading to stronger emotional reactions.
Changes in the way a person thinks. Thinking may become unusually rapid, abstract, imaginative, disorganized, or deeply introspective.
A person may feel unusually connected to themselves, others, or the environment, or experience a loss of one’s subjective self-identity.
The psychological effects can range from euphoric and reflective to fearful and disorienting. Environmental factors, emotional state, and underlying mental health conditions all influence how a person responds to the drug.
The immediate effects of mescaline can vary depending on dose, setting, and individual vulnerability. Common short-term effects include:
Visual hallucinations and sensory distortions
Euphoria or rapid emotional changes
Altered perception of time and surroundings
Dilated pupils
Sweating or dizziness
Increased heart rate and blood pressure
Nausea and vomiting, particularly with raw cactus ingestion
Some individuals may also experience severe anxiety, panic, paranoia, or confusion during intoxication. These distressing experiences are commonly referred to as a “bad trip.”
Mescaline use carries significant psychological risks, especially for individuals with existing or underlying mental health conditions. Psychedelic substances may worsen symptoms
associated with:
Anxiety Disorders
Depression
Trauma-related conditions
Psychotic disorders such as Schizophrenia
In some cases, mescaline use may trigger acute psychological distress or prolonged psychiatric symptoms.
There is also a rare but documented condition known as Hallucinogen Persisting Perception Disorder, where visual disturbances continue long after the drug has worn off. Symptoms may include visual trails, flashes of light, geometric patterns, or difficulty processing visual information.
Polysubstance use can further increase risks. Combining mescaline with alcohol, stimulants, cannabis, or other psychedelics may create unpredictable physical and psychological effects.
The drug is not generally associated with physical dependence in the same way as opioids, alcohol, or stimulants. However, repeated psychological use patterns can still develop.
Some individuals may begin using psychedelic substances as a way to cope with emotional distress, trauma, isolation, or mental health struggles. Over time, this pattern may contribute to harmful behaviours, impaired functioning, or worsening mental health symptoms.
For this reason, substance use assessments often examine not only the drug itself, but also the motivations, environment, and emotional factors surrounding use.
Under Canada’s Controlled Drugs and Substances Act, it is classified as a controlled substance. Unauthorized possession, trafficking, importation, or production is illegal.
Certain exemptions may apply for traditional ceremonial use involving peyote within specific Indigenous communities. Outside of these exemptions, recreational or unauthorized use may result in legal consequences.
Although mescaline-specific addiction treatment is relatively uncommon, individuals experiencing harmful use patterns or psychological complications can benefit from professional support and evidence-based care.
Integrated treatment is particularly important when substance use occurs alongside anxiety, depression, trauma, or other mental health concerns.
Individuals experiencing severe distress, panic, psychosis, or persistent hallucinations after mescaline use should seek immediate medical or psychological assistance.
TREATMENT APPROACHES MAY INCLUDE:
In Canada, many healthcare and public health professionals emphasize harm reduction strategies to reduce substance-related risks and improve access to care.
Harm reduction approaches related to psychedelic substances may include:
The goal of harm reduction is not to encourage drug use, but to reduce preventable harm and improve overall health outcomes.
Mescaline is a potent hallucinogenic drug with deep historical and cultural roots, but it also carries important psychological and health risks. While it is not typically linked to severe physical addiction, its effects can be unpredictable and emotionally intense.
Access to accurate information, early intervention, mental health support, and evidence-based treatment can help individuals and families better understand the risks associated with mescaline and other psychedelic substances.
For Canadians seeking help with substance use or co-occurring mental health concerns, professional assessment and integrated care remain important steps toward long-term recovery and well-being.
If you or someone you love is struggling with addiction, free and confidential support is available every day. We can help you determine and take the next step.